[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:primary-cutaneous-b-cell-lymphoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Primary cutaneous B-cell lymphoma",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05967416","Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma",[11],"Phase 1","RECRUITING","2026-08-26T02:15:43.339060Z","2026-05-05T02:43:27.815843Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06131801","Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution",[],"2026-08-26T02:15:45.413021Z","2026-05-13T02:55:06.418667Z",[],[]]